Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more ...

Inovio Pharmaceuticals Inc (INO) stock saw a decline, ending the day at $2.32 which represents a decrease of $-1.44 or -38.30% from the prior close of $3.76. The stock opened at $2.52 and touched a ...

The company is also expected to present immunological data supporting INO-3107's mechanism of action at upcoming medical conferences. While these data are not anticipated to be major catalysts for the ...

The delay in BLA submission for INO-3107 due to manufacturing issues with the CELLECTRA device could significantly impact Inovio's market position. This concern is reflected in the stock's recent ...